Ada Bertoli

2.7k total citations
59 papers, 1.2k citations indexed

About

Ada Bertoli is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Ada Bertoli has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Virology, 45 papers in Infectious Diseases and 15 papers in Epidemiology. Recurrent topics in Ada Bertoli's work include HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (42 papers) and HIV/AIDS Research and Interventions (28 papers). Ada Bertoli is often cited by papers focused on HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (42 papers) and HIV/AIDS Research and Interventions (28 papers). Ada Bertoli collaborates with scholars based in Italy, United States and Belgium. Ada Bertoli's co-authors include Carlo Federico Perno, Andrea Antinori, Federica Forbici, Francesca Ceccherini‐Silberstein, Maria Mercedes Santoro, Valentina Svicher, Antonella d’Arminio Monforte, Claudia Balotta, Caterina Gori and Michela Violin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and PLoS ONE.

In The Last Decade

Ada Bertoli

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ada Bertoli Italy	21	1.0k	952	248	196	138	59	1.2k
Carey Hwang United States	20	802 0.8×	665 0.7×	396 1.6×	250 1.3×	188 1.4×	49	1.2k
Veerle Van Eygen Belgium	18	702 0.7×	671 0.7×	199 0.8×	115 0.6×	230 1.7×	36	936
Mary O’Hearn United States	6	676 0.7×	599 0.6×	136 0.5×	77 0.4×	106 0.8×	9	838
Kabamba Kabeya Belgium	12	438 0.4×	397 0.4×	135 0.5×	73 0.4×	101 0.7×	23	638
J L Martin United States	7	827 0.8×	772 0.8×	330 1.3×	49 0.3×	246 1.8×	8	1.1k
Marina Korneyeva United States	5	566 0.6×	525 0.6×	56 0.2×	68 0.3×	99 0.7×	7	702
Steve Felstead United Kingdom	2	411 0.4×	457 0.5×	138 0.6×	44 0.2×	68 0.5×	2	605
Chris Pickford United Kingdom	10	373 0.4×	408 0.4×	137 0.6×	124 0.6×	244 1.8×	15	649
Corklin Steinhart United States	10	391 0.4×	275 0.3×	141 0.6×	74 0.4×	42 0.3×	21	566
N Montagne France	8	810 0.8×	770 0.8×	96 0.4×	45 0.2×	46 0.3×	16	924

Countries citing papers authored by Ada Bertoli

Since Specialization

Citations

This map shows the geographic impact of Ada Bertoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada Bertoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada Bertoli more than expected).

Fields of papers citing papers by Ada Bertoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ada Bertoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada Bertoli. The network helps show where Ada Bertoli may publish in the future.

Co-authorship network of co-authors of Ada Bertoli

This figure shows the co-authorship network connecting the top 25 collaborators of Ada Bertoli. A scholar is included among the top collaborators of Ada Bertoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ada Bertoli. Ada Bertoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armenia, Daniele, Roberta Gagliardini, Claudia Alteri, et al.. (2023). Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals. Journal of Clinical Virology. 168. 105551–105551. 4 indexed citations

Alteri, Claudia, Rossana Scutari, Gaetano Maffongelli, et al.. (2019). Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success. Journal of Clinical Virology. 117. 61–67. 22 indexed citations

Zaccarelli, Mauro, Maria Mercedes Santoro, Daniele Armenia, et al.. (2016). Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA. Journal of Clinical Virology. 82. 94–100. 28 indexed citations

Fabeni, Lavinia, Claudia Alteri, Nicoletta Orchi, et al.. (2015). Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy. PLoS ONE. 10(8). e0135325–e0135325. 11 indexed citations

Maffongelli, Gaetano, Claudia Alteri, Elisa Gentilotti, et al.. (2015). Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy. AIDS. 30(5). 731–741. 11 indexed citations

Alteri, Claudia, Anna Artese, Maria Mercedes Santoro, et al.. (2013). Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen. Journal of Antimicrobial Chemotherapy. 68(10). 2205–2209. 7 indexed citations

d’Ettorre, Gabriella, Alessandra Lo Presti, Caterina Gori, et al.. (2013). An HIV Type 2 Case Series in Italy: A Phylogenetic Analysis. AIDS Research and Human Retroviruses. 29(9). 1254–1259. 5 indexed citations

Cento, Valeria, Carmen Mirabelli, Romina Salpini, et al.. (2012). HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors. PLoS ONE. 7(7). e39652–e39652. 72 indexed citations

Ciccozzi, Massimo, Muhammed Babakir‐Mina, Eleonora Cella, et al.. (2011). A Case of Italian HIV Type 2 Infection: A Genetic Analysis. AIDS Research and Human Retroviruses. 27(12). 1333–1335. 6 indexed citations

10.

Alteri, Claudia, Anna Artese, Giosuè Costa, et al.. (2011). Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus. Nano Letters. 39(1). 45–50. 5 indexed citations

11.

Sarrecchia, C., Valentina Svicher, Antonio Volpi, et al.. (2011). Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. Infection. 39(4). 367–370. 1 indexed citations

12.

Santoro, Maria Mercedes, Ada Bertoli, Patrizia Lorenzini, et al.. (2009). Two Different Patterns of Mutations are Involved in the Genotypic Resistance Score for Atazanavir Boosted Versus Unboosted by Ritonavir in Multiple Failing Patients. Infection. 37(3). 233–243. 7 indexed citations

13.

Tozzi, Valerio, Rita Bellagamba, Filippo Castiglione, et al.. (2008). Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART. AIDS Research and Human Retroviruses. 24(6). 787–796. 4 indexed citations

14.

Santoro, Maria Mercedes, Ada Bertoli, Patrizia Lorenzini, et al.. (2007). Viro-Immunologic Response to Ritonavir-Boosted or Unboosted Atazanavir in a Large Cohort of Multiply Treated Patients: The CARe Study. AIDS Patient Care and STDs. 22(1). 7–16. 8 indexed citations

15.

Ceccherini‐Silberstein, Francesca, Valentina Svicher, Tobias Sing, et al.. (2005). Involvement of novel HIV-1 reverse transcriptase mutations in the highly ordered regulation of NRTI resistance. Antiviral Therapy. 10(4). 2 indexed citations

16.

Bertoli, Ada, Maribel Franco, Jan Balzarini, Magnus Johansson, & Anna Karlsson. (2005). Altered deoxyribonucleotide pools in T‐lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster. FEBS Journal. 272(15). 3918–3928. 8 indexed citations

17.

Violin, Michela, Alessandro Cozzi‐Lepri, M. A. Vincenti, et al.. (2004). Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy. AIDS. 18(2). 227–235. 87 indexed citations

18.

Luca, Andrea De, Antonella Cingolani, Simona Di Giambenedetto, et al.. (2003). Variable Prediction of Antiretroviral Treatment Outcome by Different Systems for Interpreting Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance. The Journal of Infectious Diseases. 187(12). 1934–1943. 83 indexed citations

19.

Violin, Michela, Alessandro Cozzi‐Lepri, Ada Bertoli, et al.. (2002). Transmitted virus with substitutions at position 215 and risk of virological failure in antiretroviral-naive patients starting highly active antiretroviral therapy. UCL Discovery (University College London). 6 indexed citations

20.

Perno, Carlo Federico, Alessandro Cozzi‐Lepri, Claudia Balotta, et al.. (2002). Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation. AIDS. 16(4). 619–624. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact